If you're an income investor on the lookout for some new additions to your portfolio, then read on.
That's because listed below are three ASX dividend shares that brokers have recently been named as buys.
Here's what sort of dividend yields you can expect from them:
Image source: Getty Images
Accent Group Ltd (ASX: AX1)
Analysts at Bell Potter think that the owner of The Athlete's Foot, Stylerunner, and HYPEDC could be an ASX dividend share to buy.
The broker currently has a buy rating and $2.50 price target on its shares.
As for income, it is forecasting fully franked dividends per share of 12 cents in FY 2024 and then 14.1 cents in FY 2025. Based on the current Accents share price of $2.09, this represents dividend yields of 5.75% and 6.7%, respectively.
Endeavour Group Ltd (ASX: EDV)
Another ASX dividend share that brokers rate as a buy is BWS and Dan Murphy's owner Endeavour.
Goldman Sachs is fan of the company and feels its valuation is attractive given its "clear market leading position." It has a buy rating and $6.40 price target on the company's shares.
In respect to dividends, the broker is forecasting fully franked dividends of approximately 21 cents per share in FY 2024 and 23 cents per share in FY 2025. Based on the current Endeavour share price of $5.74, this will mean yields of 3.7% and 4%, respectively.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Finally, brokers are saying that Healthco Healthcare and Wellness REIT is an ASX dividend share to buy.
It is a leading health and wellness-focused real estate investment trust that owns a high quality, portfolio of assets such as hospitals, aged care facilities, and primary care properties.
Morgans is bullish and has an add rating and $1.67 price target on its shares.
As for income, it is expecting the company to pay dividends per share of 8 cents in both FY 2024 and FY 2025. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.37, this will mean yields of 5.8% in both years.
